Advertisement
U.S. Markets open in 4 hrs 59 mins

Bone Biologics Corporation (BBLGW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
11.00+9.34 (+562.65%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.66
Open3.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.00 - 11.00
52 Week Range0.70 - 70.44
Volume3,009
Avg. Volume53
Market CapN/A
Beta (5Y Monthly)0.70
PE Ratio (TTM)N/A
EPS (TTM)-0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

    BURLINGTON, Mass., September 04, 2024--Bone Biologics Corporation ("Bone Biologics" or the "Company") (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that Jeffrey Frelick, chief executive officer, will present virtually at the H.C. Wainwright 26th Annual Global Investment Conference being held September 9-11, 2024 in New York City. Bone Biologics’ company presentation will be available here beginning on Monday, September 9th at 7:00 a.m. Eastern t

  • Medical Device Network

    LifeNet launches newest bone allograft gel with Johnson & Johnson

    Designed in Virginia and commericalised by Johnson & Johnson, Lifenet Health’s bone allograft is aims to help surgeons expedite procedures.